GE HealthCare Technologies Inc. with ticker code (GEHC) have now 15 confirmed analysts covering the stock with the consensus suggesting a rating of ‘buy’. The target price High/Low ranges between $105.00 and $84.00 with the average share target price sitting at $94.35. (at the time of writing). Given that the stocks previous close was at $83.40 and the analysts are correct then we can expect a percentage increase in value of 13.1%. The 50 day moving average now sits at $79.30 and the 200 moving average now moves to $79.54. The total market capitalization for the company now stands at 37.62B. The stock price is currently at: $82.37 USD
The potential market cap would be $42,553,944,543 based on the market consensus.
The company has a dividend yield of 0.77%. Other points of data to note are a P/E ratio of 23.81, revenue per share of $42.85 and a 5.73% return on assets.
GE HealthCare Technologies Inc. is a global medical technology, pharmaceutical diagnostics, and digital solutions company. The Company develops, manufactures, and markets a portfolio of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients. The Company’s segments include Imaging, Ultrasound, Patient Care Solutions and Pharmaceutical Diagnostics. The Imaging segment includes scanning devices, clinical applications, service capabilities and digital solutions. The Ultrasound segment includes screening, diagnosis, treatment, and monitoring of certain diseases. The Patient Care Solutions segment includes medical devices, services, consumable products, services, and digital solutions. The Pharmaceutical Diagnostics segment is a supplier of diagnostic agents to the global radiology and nuclear medicine industry.
